Why companies spend millions on crash test dummies

Why companies spend millions on crash test dummies


A car buyer may never see crash test dummies, but they are a crucial piece of what keeps pushing automotive safety forward.

The latest crash test dummies are loaded with sensors and new tech, and they can cost $1 million. Major automakers and suppliers can have fleets of dozens of dummies. New dummies are also made to be more biofidelic, which means true to the actual shape and features of the human body.

Humanetics, the world’s leading maker of crash test dummies, has paid specific attention to making its latest generation female dummy more true to the shape of actual women. The female dummy most commonly in use today, called the Hybrid III 5F, is basically a shrunken version of the male Hybrid III dummy, with male proportions and weight distribution.

The latest generation frontal impact dummies have a greater array of sensors, onboard computers and designs that are meant to better resemble the heftier people of today. The average American has gained a few pounds since the early 1980s, when the previous generation was made.

Automakers and some vehicle testing groups around the world have already adopted the latest dummies, but some have held back, including the U.S. government.

To learn more, watch the video.



Source

Nike cuts 1,400 roles in second round of layoffs this year
Business

Nike cuts 1,400 roles in second round of layoffs this year

People walk past a Nike store in New York City, on April 2, 2025. Kylie Cooper | Reuters Nike announced a new round of layoffs on Thursday impacting approximately 1,400 roles across the organization, mostly concentrated in its technology department. In a note from COO Venkatesh Alagirisamy, the company said the layoffs were part of […]

Read More
Trump administration moves to reclassify cannabis in major shift that could expand research
Business

Trump administration moves to reclassify cannabis in major shift that could expand research

The Trump administration moved Thursday to reclassify cannabis under federal law, which could significantly expand scientific research into the drug’s medical uses. The change would not legalize the drug at the federal level, but shift cannabis from its current status as a Schedule I substance to Schedule III under the U.S. Drug Enforcement Administration’s controlled […]

Read More
Regeneron inks drug pricing deal with Trump, will offer new hearing-loss therapy for free
Business

Regeneron inks drug pricing deal with Trump, will offer new hearing-loss therapy for free

U.S. President Donald Trump (C) speaks during an event on advancing health care affordability in the Oval Office of the White House on April 23, 2026 in Washington, DC. Alex Wong | Getty Images Regeneron agreed to lower U.S. drug prices for some Americans as part of a deal with President Donald Trump, the White […]

Read More